Red blood cell abnormalities in hereditary elliptocytosis and their relevance to variable clinical expression

American Journal of Clinical Pathology

Volumn 108, Issue 4, 1997, Pages 391-399

  Silveira, Paolo ^a   Cynober, Thérèse ^a   Dhermy, Didier ^a   Mohandas, Narla ^b,c   Tchernia, Gil ^a  

^a BICÊTRE HOSPITAL   (France)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

Hemolytic anemia; Hereditary elliptocytosis; Membrane disorders; Red blood cells

Indexed keywords

ERYTHROCYTE BAND 4.1 PROTEIN; HEMOGLOBIN; MUTANT PROTEIN; SPECTRIN;

ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; ERYTHROCYTE DEFORMABILITY; ERYTHROCYTE DISORDER; ERYTHROCYTE VOLUME; FEMALE; HEREDITARY ELLIPTOCYTOSIS; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; RETICULOCYTE COUNT;

EID: 0030802681     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/108.4.391     Document Type: Article

References (14)

1. Lux SE, Palek J. Disorders of the red cell membrane. Blood: Principles and Practice of Hematology. Handin RI, Lux SE, Stossel TP, eds. Philadelphia, Pa: JB Lippincott; 1995:1701-1816.
2. Alloisio N, Dorleac E, Delaunay J, Girot R, Galand C, Boivin P. A shortened variant of red cell membrane protein 4.1. Blood. 1982;60:265-267.
3. Alloisio N, Morle L, Dorleac E, et al. The heterozygous form of 4.1 (-) hereditary elliptocytosis [the 4.1 (-) trait]. Blood. 1985;65:46-51.
4. Delaunay J, Dhermy D. Mutations involving the spectrin heterodimer contact site: clinical expression and alterations in specific function. Semin Hematol. 1993;30:21-33.
5. Gallagher PG, Tse WT, Pothier B, et al. Molecular basis of shortened β spectrin chains in hereditary elliptocytosis (HE): a splice site mutation and exon skipping in spectrin Le Puy and a frameshift due to a two base insertion in spectrin Nice. Blood. 1990;76(suppl 1):8a.
6. Marchesi SL, Letsinger JT, Speicher DW, et al. Mutant forms of spectrin alpha-subunits in hereditary elliptocytosis. J Clin Invest. 1987;80:191-198.
7. Marchesi S, Conboy J, Agre P, et al. Molecular analysis of insertion/deletion mutations in protein 4.1 in elliptocytosis: biochemical identification of rearrangements in the spectrin/actin binding domain and functional characterizations. J Clin Invest. 1990;86:516-523.
8. McGuire M, Smith BL, Agre P. Distinct variants of erythrocyte protein 4.1 inherited in linkage with elliptocytosis and Rh type in three white families. Blood. 1988;72:287-293.
9. Mentzer WC, Turetsky T, Mohandas N, Schrier S, Wu CS, Koenig H. Identification of the hereditary pyropoikilocytosis carrier state. Blood. 1984;63:1436-1439.
10. Mohandas N, Chasis JA. Red cell deformability, membrane material properties and shape: regulation by transmembrane, skeletal and cytosolic proteins and lipids. Semin Hematol. 1993;30:171-192.
11. Palek J, Jarolim P. Clinical expression and laboratory detection of red blood cell membrane protein mutations. Semin Hematol. 1993;30:249-283.
12. Tchernia G, Mohandas N, Shohet SB. Deficiency of skeletal membrane protein 4.1 in homozygous hereditary elliptocytosis. J Clin Invest. 1981;68:454-160.
13. Lecomte MC, Dhermy D, Garbarz M. Hereditary elliptocytosis in West Africa: frequency and repartition of spectrin variants. C R Acad Sci III. 1988;306:43-46.
14. Mohandas N, Kim YR, Tycko DH, Orlik J, Wyatt J, Groner W. Accurate and independent measurement of volume and hemoglobin concentration of individual red cells by laser light scattering. Blood. 1986;68:506-513.